Targeting Myeloid Cells to Fight Cancer

Targeting Myeloid Cells to Fight Cancer PDF Author: Maija Hollmén
Publisher: Frontiers Media SA
ISBN: 2889633934
Category :
Languages : en
Pages : 150

Get Book Here

Book Description

Targeting Myeloid Cells to Fight Cancer

Targeting Myeloid Cells to Fight Cancer PDF Author: Maija Hollmén
Publisher: Frontiers Media SA
ISBN: 2889633934
Category :
Languages : en
Pages : 150

Get Book Here

Book Description


Cancer Immunotherapy

Cancer Immunotherapy PDF Author: Saul J. Priceman
Publisher: Elsevier Inc. Chapters
ISBN: 0128059222
Category : Medical
Languages : en
Pages : 33

Get Book Here

Book Description
Tumor-associated immune cells, in particular myeloid cells, have opposing roles during cancer development by facilitating antitumor immune responses and driving cancer-promoting inflammation. Defective antitumor immunity is prevalent in cancers, and it is now clear that overcoming the myeloid cell-mediated immunosuppressive microenvironment poses tremendous interest for future cancer therapies. JAK/STAT signaling has come to the forefront as a crucial pathway to induce immunosuppression and procancer inflammation. Specifically, STAT3 activation is critical for the phenotype of myeloid cells by regulating immunosuppressive and prometastatic factors, thereby providing myeloid cells with a multitude of tumor-promoting functions. Genetic ablation of STAT3 in the myeloid compartment induces potent innate and adaptive antitumor immunity along with an inhibition of tumor growth and metastasis. Recently, therapeutic targeting of JAK/STAT3 has shown great promise in blocking immunosuppression in preclinical models. One such example is the use of novel siRNA to selectively target STAT3 in myeloid cells, through conjugation to CpG oligonucleotides that agonize Toll receptor TLR9 on myeloid cells. Along with other novel therapeutic strategies to inhibit JAK/STAT signaling, it seems likely that future efforts to target this pathway will be made in single and combination approaches for effective anticancer immunotherapy.

Roles of Tumor-Recruited Myeloid Cells in Immune Evasion in Cancer

Roles of Tumor-Recruited Myeloid Cells in Immune Evasion in Cancer PDF Author: Sergei Kusmartsev
Publisher: Frontiers Media SA
ISBN: 2889714985
Category : Medical
Languages : en
Pages : 202

Get Book Here

Book Description


Myeloid-Derived Suppressor Cells and Cancer

Myeloid-Derived Suppressor Cells and Cancer PDF Author: David Escors
Publisher: Springer
ISBN: 331926821X
Category : Medical
Languages : en
Pages : 109

Get Book Here

Book Description
The book starts with an introduction to and history of myeloid-derived suppressor cells (MDSCs), followed by a description of their differentiation, their role in the tumour microenvironment and their therapeutic targeting. It closes with an outlook on future developments. In cancer patients, myelopoiesis is perturbed and instead of generating immunogenic myeloid cells (such as dendritic cells, inflammatory macrophages and granulocytes), there is an increase in highly immature MDSCs. These cells are distributed systemically, resulting in general immunosuppression. They also infiltrate tumours, promoting their progression and metastasis by inhibiting the natural anti-tumour immune response. As these cells also interact with classical anti-neoplastic treatments, they have become major therapeutic targets in the pharmaceutical industry and in oncology research.

Targeting the Tumor Microenvironment for a More Effective and Efficient Cancer Immunotherapy

Targeting the Tumor Microenvironment for a More Effective and Efficient Cancer Immunotherapy PDF Author: Salem Chouaib
Publisher: Frontiers Media SA
ISBN: 2889638170
Category :
Languages : en
Pages : 196

Get Book Here

Book Description


Enhancing Immunotherapy for Cancer by Targeting Suppressive Myeloid Cells

Enhancing Immunotherapy for Cancer by Targeting Suppressive Myeloid Cells PDF Author: Brooke N. Benner
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 149

Get Book Here

Book Description


NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy

NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy PDF Author: Erik Wennerberg
Publisher: Frontiers Media SA
ISBN: 2889712710
Category : Medical
Languages : en
Pages : 144

Get Book Here

Book Description


Enhancing Immune Therapy for Cancer by Targeting Myeloid Derived Suppressor Cells

Enhancing Immune Therapy for Cancer by Targeting Myeloid Derived Suppressor Cells PDF Author: Andrew Robert Stiff
Publisher:
ISBN:
Category : Immune system
Languages : en
Pages :

Get Book Here

Book Description
While some of the mechanisms that cause impaired NK cell and T cell function are linked to processes inherent to tumor cells such as cytokine production and metabolic alterations it is also clear that cancer is linked to the expansion of multiple immune suppressive cell populations such as regulatory T cells (Treg), tumor associated macrophages (TAMs), and myeloid derived suppressor cells (MDSC).

Therapeutic targeting Of MDSC in the tumor and immune microenvironment

Therapeutic targeting Of MDSC in the tumor and immune microenvironment PDF Author: Erika Adriana Eksioglu
Publisher: Frontiers Media SA
ISBN: 2832541496
Category : Medical
Languages : en
Pages : 131

Get Book Here

Book Description


New Targeting in The Reversal of Resistant Glioblastomas

New Targeting in The Reversal of Resistant Glioblastomas PDF Author: Ali Syed Arbab
Publisher: Academic Press
ISBN: 0128232765
Category : Science
Languages : en
Pages : 204

Get Book Here

Book Description
New Targeting in The Reversal of Resistant Glioblastomas discusses alternative treatment strategies that not only target tumor cells but also target the tumor microenvironment, metabolic pathways and interaction of cytokines in tumor cells. The current treatment for primary and recurrent glioblastomas is failing because clinicians are not considering the effect of bone marrow derived cells to the development of resistance to clinically practiced therapies. This book helps readers rethink treatment strategies to successfully fight glioblastomas. It is a valuable resource for cancer researchers, clinicians, graduate students and other members of the biomedical field. Explains the effect of bone marrow derived cells on the development of resistance to clinically practiced therapies Provides information on the availability of alternate therapies for recurrent glioblastoma when standard practices have failed Discusses targeting tumor microenvironment using available FDA approved drugs as an alternative treatment strategy for glioblastoma